midi compounded semaglutide Injectable | GLP-1 Ivím Health | Compounded Semaglutide

you lose weight, not playing catch-up afterward

There is currently no strong evidence to support or rule out GLP-1s causing diseases like pancreatic or thyroid cancer

They also slow down how quickly food leaves your stomach, so you stay fuller for longer

Retatrutide (LY3437943) is a first-in-class triple-receptor agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon

Recently, a large study identified a higher rate of acne in women using GLP-1 medications compared to those who werent